Published in Acta Psychiatr Scand Suppl on January 01, 1983
Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet (2000) 3.05
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol (1998) 1.51
Therapeutic efficacy of specific serotonin reuptake inhibitors (SSRIs) in dysthymia. Can J Psychiatry (1994) 1.48
Thyrotropin releasing hormone potentiates the effects of imipramine on brain serotonergic system. Brain Res Bull (1981) 1.39
Treatment of major affective disorder with fluvoxamine. J Clin Psychiatry (1987) 1.06
Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol Psychiatry (1999) 1.03
Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci (1995) 0.97
Quantitative EEG in the prediction of antidepressant response to imipramine. J Affect Disord (1996) 0.97
A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis. J Clin Psychiatry (1982) 0.92
Retention rates in placebo- and nonplacebo-controlled clinical trials of schizophrenia. Can J Psychiatry (1999) 0.90
Benzodiazepine withdrawal. Can J Psychiatry (1981) 0.89
Evidence for the role of brain norepinephrine and dopamine in "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines. J Psychiatr Res (1977) 0.88
Koro in a French Canadian. Can Psychiatr Assoc J (1972) 0.88
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res (1997) 0.87
Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Res (1999) 0.86
A comparison of placebo responders and nonresponders in subgroups of depressive disorder. J Psychiatry Neurosci (1995) 0.86
Are all benzodiazepines clinically equivalent? Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.86
Gas--liquid chromatographic determination of pipotiazine in plasma of psychiatric patients. J Chromatogr (1981) 0.85
Diazepam and benzoctamlne: effects on certain objective parameters of muscular spasticity. Curr Ther Res Clin Exp (1973) 0.85
Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride Group. J Psychiatry Neurosci (1997) 0.83
Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients. J Psychiatry Neurosci (1993) 0.82
Effective treatment of mania with olanzapine: 2 case reports. J Psychiatry Neurosci (1997) 0.82
Computerized EEG correlates of depression and antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.82
Fluphenazine, trifluoperazine and perphenazine in Vacutainers. Can Med Assoc J (1981) 0.82
Some neurochemical correlates of "rebound" phenomenon observed during withdrawal after long-term exposure to 1, 4-benzodiazepines. Prog Neuropsychopharmacol (1978) 0.82
Photophobia in depression. Am J Psychiatry (1989) 0.81
Preparatory brain potentials in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.81
[Mesoridazine therapy in neurotics-clinical trial]. Union Med Can (1972) 0.81
Psychophysiological correlates of sodium lactate. Psychopharmacol Bull (1984) 0.80
Auditory evoked potentials in panic disorder. J Psychiatry Neurosci (1991) 0.80
Effects of lactate-induced panic attacks on brain stem auditory evoked potentials. Neuropsychobiology (1986) 0.80
Electrophysiological and behavioral correlates of psychomotor responsivity in depression. Biol Psychiatry (1987) 0.80
A controlled study of penfluridol in the treatment of chronic schizophrenia. Am J Psychiatry (1978) 0.80
Pimozide and the social behavior of schizophrenics. Curr Ther Res Clin Exp (1975) 0.79
Validity and sensitivity of the french version of the Zerssen BfS/BfS' self-rating mood scale during treatment with trazodone and amitriptyline. Prog Neuropsychopharmacol (1981) 0.79
Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder. J Clin Psychopharmacol (1993) 0.79
Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency? J Neural Transm (1983) 0.79
Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics. Int J Clin Pharmacol Biopharm (1975) 0.79
Selective dopamine D2 antagonist and prolactin response in acute schizophrenia--results from remoxipride studies. The Canadian Remoxipride Study Group. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.78
Agitated and retarded depression. A clinical psychophysiological evaluation. Neuropsychobiology (1980) 0.78
SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients. Int Clin Psychopharmacol (1995) 0.78
Cis- and trans-isomers of doxepin and desmethyldoxepin in the plasma of depressed patients treated with doxepin. Ther Drug Monit (1990) 0.78
Neuropsychophysiological correlates of lactate-induced panic. Prog Neuropsychopharmacol Biol Psychiatry (1988) 0.78
Mianserin kinetics in depressed patients. Clin Pharmacol Ther (1983) 0.78
Effects of cholinergic and GABAergic drugs on apomorphine-induced gnawing behavior in rats. Biol Psychiatry (1982) 0.77
Temporal segmentation of response speed in depression: neuro-electrophysiological approaches. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.77
Efficacy of lithium in treating mood disorder occurring after brain stem injury. Am J Psychiatry (1981) 0.77
Panic induced by sodium lactate: electrophysiological correlates. Prog Neuropsychopharmacol (1981) 0.77
Platelet serotonin measures in primary dysthymia. Am J Psychiatry (1994) 0.77
Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines. Psychopharmacology (Berl) (1980) 0.77
Fluvoxamine influences serotonergic system in the brain: neurochemical evidence. Neuropsychobiology (1983) 0.76
Control of lithium tremor with propranolol. Can Med Assoc J (1976) 0.76
Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.76
Rapid recurrence of mania following lithium withdrawal. Biol Psychiatry (1980) 0.76
Effects of short- and long-term neuroleptic treatment on brain serotonin synthesis and turnover: focus on the serotonin hypothesis of schizophrenia. Life Sci (1981) 0.76
Phenothiazine treatment and electrocardiographic abnormalities. Can Psychiatr Assoc J (1969) 0.76
Comparison of chlormethiazole (Heminevrin) and chlordiazepoxide (Librium) in the treatment of acute alcohol withdrawal. Neuropsychobiology (1983) 0.76
Anxiety disorders. Part 1: Diagnosis and treatment. Can Fam Physician (1993) 0.75
Pharmacokinetics of psychotropic drugs: what can it tell us? Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.75
Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepam. Br J Pharmacol (1977) 0.75
Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients. J Psychiatry Neurosci (1991) 0.75
Anxiety disorders. Part 2: Pharmacotherapy with benzodiazepines. Can Fam Physician (1993) 0.75
Lithium intoxication. Can Med Assoc J (1972) 0.75
Clinical-trial registration. CMAJ (1994) 0.75
Placebo: a potent but misunderstood psychotrope. J Psychiatry Neurosci (1995) 0.75
Ethics and placebo. J Psychiatry Neurosci (1998) 0.75
Rapid reduction of mania by means of reserpine therapy. Am J Psychiatry (1986) 0.75
Cholinesterases in primary affective disorders. Clin Biochem (1985) 0.75
Diazepam modifies L-triiodothyronine-stimulated changes in behaviour and the metabolism of brain norepinephrine, dopamine and 5-hydroxytryptamine-a possible mechanism of action. J Psychiatr Res (1979) 0.75
Effects of apomorphine on behavioural activity and brain catecholamine synthesis in normal and L-triiodothyronine-treated rats. J Neural Transm (1981) 0.75
The use of tryptophan in normal-weight bulimia. Can J Psychiatry (1986) 0.75
Therapeutic use of the tricyclic-induced switch in bipolar manic-depression. Am J Psychiatry (1982) 0.75
Zopiclone in the treatment of insomniacs of family practice. Psychiatr J Univ Ott (1985) 0.75
The effect of methylphenidate on tardive dyskinesia. Prog Neuropsychopharmacol (1981) 0.75
Clinical effects of mianserin in endogenous depression and their relationship to drug plasma level. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.75
Pharmacologic management of aggressivity and self-mutilation in the mentally retarded. Psychiatr Clin North Am (1986) 0.75
Suriclone: a new anxiolytic drug. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.75
Disulfiram and bipolar affective disorder: a case report. J Clin Psychopharmacol (1986) 0.75
Myalgia with the new generation antidepressants. J Clin Psychopharmacol (1986) 0.75
Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain. Adv Biochem Psychopharmacol (1980) 0.75
Antidepressant plasma levels and clinical response in depressed patients treated with oxaprotiline and doxepin. Int Clin Psychopharmacol (1988) 0.75
Therapeutic monitoring of treatment with antidepressants. Psychiatr J Univ Ott (1989) 0.75
The effect of buspirone on panic disorder: a case report. J Clin Psychopharmacol (1987) 0.75
Lithium as an adjunct in the treatment of major depression. Int Clin Psychopharmacol (1990) 0.75
Nomifensine overdose with TCAs and MAOIs. J Clin Psychopharmacol (1986) 0.75
Secondary mania associated with sympathomimetic drug use. Am J Psychiatry (1981) 0.75
Altered amitriptyline kinetics in a depressed patient with porto-caval anastomosis. Can J Psychiatry (1985) 0.75
Neurochemical changes produced by acute treatment with clobazam, a new 1,5-benzodiazepine. Gen Pharmacol (1981) 0.75
Reversal of learned helplessness by nortriptyline. Prog Neuropsychopharmacol (1981) 0.75
Erythrocyte membrane sodium-potassium and magnesium ATPase in primary affective disorder. Biol Psychiatry (1985) 0.75
Clinical and biological correlates of panic states. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.75
Abnormal involuntary movements in patients on long-acting neuroleptics. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.75
Course of clinical response to antidepressants. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.75
Plasma concentration of remoxipride in relation to antipsychotic effect and adverse symptoms. The Canadian Remoxipride Study Group. Acta Psychiatr Scand Suppl (1990) 0.75
Plasma levels of maprotiline and zimelidine and their relationship to clinical response in depressed patients. Ther Drug Monit (1986) 0.75
[The hospitalized fraternal pair: study of family relations]. Laval Med (1970) 0.75
Simultaneous mesoridazine and psychodrama in neurotics. Int J Clin Pharmacol (1973) 0.75
Keratodermia: side effects of lithium. J Clin Psychopharmacol (1991) 0.75
Effects of rubidium and cesium on central catecholamines and locomotor behavior in rats. J Neurochem (1980) 0.75
Clinical response, plasma levels and pharmacokinetics of desipramine in depressed in-patients. Prog Neuropsychopharmacol (1980) 0.75